Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | 0.00% | 0.00% | 0.00% |
2023 | Motion for Asset Sale Approved for OncoSec Medical Incorporated | CI |
2023 | Motion for Asset Sale Filed by OncoSec Medical Incorporated | CI |
Sales 2021 | - | Sales 2022 | - | Capitalization | 28.35M 38.71M |
---|---|---|---|---|---|
Net income 2021 | -45M -61.44M | Net income 2022 | -34M -46.42M | EV / Sales 2021 | - |
Net cash position 2021 | 33.63M 45.92M | Net cash position 2022 | 1.12M 1.54M | EV / Sales 2022 | - |
P/E ratio 2021 |
-1.59
x | P/E ratio 2022 |
-0.83
x | Employees | 41 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 84.57% |
Current month | +100.00% | ||
1 month | +100.00% | ||
3 months | +100.00% | ||
6 months | -99.31% |
Managers | Title | Age | Since |
---|---|---|---|
David Canton
CTO | Chief Tech/Sci/R&D Officer | - | 13-12-31 |
Sandra Aung
PRN | Corporate Officer/Principal | - | 20-10-11 |
Bridget O'Keeffe
PRN | Corporate Officer/Principal | - | 21-02-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | - | +-NaN% | 1 |
24-04-25 | - | -100.00% | 37 |
24-04-23 | 0.0002 | +∞% | 3,944 |
24-04-19 | - | -100.00% | 1 |
Delayed Quote OTC Markets, April 23, 2024 at 12:40 pm
More quotes1st Jan change | Capi. | |
---|---|---|
0.00% | 1.19K | |
+1.51% | 42.75B | |
+48.37% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- ONCSQ Stock